Cover Image
市場調查報告書

的感染疾病診斷市場預測EU5個國家

EU5 Infectious Diagnostics Market Outlook to 2021

出版商 GlobalData 商品編碼 348476
出版日期 內容資訊 英文 169 Pages
訂單完成後即時交付
價格
Back to Top
的感染疾病診斷市場預測EU5個國家 EU5 Infectious Diagnostics Market Outlook to 2021
出版日期: 2015年10月05日 內容資訊: 英文 169 Pages
簡介

本報告提供EU5個國家感染疾病診斷市場相關調查分析,提供您各市場區隔的收益實際成果·預測,不同分類的企業佔有率·流通佔有率,主要企業簡介等系統性資訊。

第1章 目錄

第2章 簡介

第3章 EU5個國家的感染疾病診斷市場

  • 收益
  • 類別比較:各收益
  • 收益實際成果
  • 收益預測
  • 企業佔有率:各收益

第4章 法國的感染疾病診斷市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第5章 德國的感染疾病診斷市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第6章 義大利的感染疾病診斷市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第7章 西班牙的感染疾病診斷市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第8章 英國的感染疾病診斷市場

  • 收益實際成果
  • 收益預測
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第9章 EU5個國家的感染疾病診斷市場主要企業概要

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare
  • Qiagen N.V.
  • DiaSorin S.p.A
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux S.A.
  • Becton, Dickinson and Company
  • Danaher Corporation

第10章 感染疾病診斷市場開發中產品

第11章 最近的發展

  • 企業宣傳
  • 公佈財報
  • 法律規章
  • 其他重要的發展
  • 產品新聞
  • 策略和產業計畫

第12章 附錄

圖表

目錄
Product Code: GDMECR0333DB

GlobalData's new report, "EU5 Infectious Diagnostics Market Outlook to 2021", provides key market data on the EU5 Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Infectious Diagnostics market.
  • Global corporate-level profiles of key companies operating within the EU5 Infectious Diagnostics market.
  • Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Infectious Diagnostics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Infectious Diagnostics Market, EU5

  • 3.1. Infectious Diagnostics Market, EU5, Revenue ($m), 2007-2021
  • 3.2. Infectious Diagnostics Market, EU5, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Infectious Diagnostics Market, EU5, Revenue ($m), 2007-2014
  • 3.4. Infectious Diagnostics Market, EU5, Revenue ($m), 2014-2021
  • 3.5. Infectious Diagnostics Market, EU5, Company Share by Revenue ($m), 2014

4. Infectious Diagnostics Market, France

  • 4.1. Infectious Diagnostics Market, France, Revenue ($m), 2007-2014
  • 4.2. Infectious Diagnostics Market, France, Revenue ($m), 2014-2021
    • 4.2.1. Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), by Segment, 2014-2021
  • 4.3. Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), 2013-2014
  • 4.4. Infectious Diagnostics Market, France, Company Share by Revenue ($m), 2014

5. Infectious Diagnostics Market, Germany

  • 5.1. Infectious Diagnostics Market, Germany, Revenue ($m), 2007-2014
  • 5.2. Infectious Diagnostics Market, Germany, Revenue ($m), 2014-2021
    • 5.2.1. Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), by Segment, 2014-2021
  • 5.3. Infectious Diagnostics Market, Germany, Distribution Share by Revenue ($m), 2013-2014
  • 5.4. Infectious Diagnostics Market, Germany, Company Share by Revenue ($m), 2014

6. Infectious Diagnostics Market, Italy

  • 6.1. Infectious Diagnostics Market, Italy, Revenue ($m), 2007-2014
  • 6.2. Infectious Diagnostics Market, Italy, Revenue ($m), 2014-2021
    • 6.2.1. Infectious Diagnostics Rapid Tests & POC Market, Italy, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Infectious Diagnostics Rapid Tests & POC Market, Italy, Revenue ($m), by Segment, 2014-2021
  • 6.3. Infectious Diagnostics Market, Italy, Distribution Share by Revenue ($m), 2013-2014
  • 6.4. Infectious Diagnostics Market, Italy, Company Share by Revenue ($m), 2014

7. Infectious Diagnostics Market, Spain

  • 7.1. Infectious Diagnostics Market, Spain, Revenue ($m), 2007-2014
  • 7.2. Infectious Diagnostics Market, Spain, Revenue ($m), 2014-2021
    • 7.2.1. Infectious Diagnostics Rapid Tests & POC Market, Spain, Revenue ($m), by Segment, 2007-2014
    • 7.2.2. Infectious Diagnostics Rapid Tests & POC Market, Spain, Revenue ($m), by Segment, 2014-2021
  • 7.3. Infectious Diagnostics Market, Spain, Distribution Share by Revenue ($m), 2013-2014
  • 7.4. Infectious Diagnostics Market, Spain, Company Share by Revenue ($m), 2014

8. Infectious Diagnostics Market, United Kingdom

  • 8.1. Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2007-2014
  • 8.2. Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2014-2021
    • 8.2.1. Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), by Segment, 2007-2014
    • 8.2.2. Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), by Segment, 2014-2021
  • 8.3. Infectious Diagnostics Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014
  • 8.4. Infectious Diagnostics Market, United Kingdom, Company Share by Revenue ($m), 2014

9. Overview of Key Companies in EU5 Infectious Diagnostics Market

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
  • 9.2. F. Hoffmann-La Roche Ltd.
    • 9.2.1. Company Overview
  • 9.3. Siemens Healthcare
    • 9.3.1. Company Overview
  • 9.4. Qiagen N.V.
    • 9.4.1. Company Overview
  • 9.5. DiaSorin S.p.A
    • 9.5.1. Company Overview
  • 9.6. Alere Inc.
    • 9.6.1. Company Overview
  • 9.7. Bio-Rad Laboratories, Inc.
    • 9.7.1. Company Overview
  • 9.8. bioMerieux S.A.
    • 9.8.1. Company Overview
  • 9.9. Becton, Dickinson and Company
    • 9.9.1. Company Overview
  • 9.10. Danaher Corporation
    • 9.10.1. Company Overview

10. Infectious Diagnostics Market Pipeline Products

11. Recent Developments

  • 11.1. Corporate Communications
    • 11.1.1. Jun 25, 2015: Cardiac Dimensions Announces Initial Enrollments in REDUCE FMR Clinical Trial
    • 11.1.2. Jun 18, 2015: Dutch hospital acquires 1,000th Agility, Elekta's radiotherapy beam-shaping technology for treating cancer
    • 11.1.3. May 11, 2015: Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer
    • 11.1.4. May 08, 2015: Change in Roche Board of Directors
    • 11.1.5. Mar 05, 2015: New Study in Journal of Tissue Viability Recognizes SEM Scanner's Clinical Utility in Detection of Pressure Ulcers
  • 11.2. Financial Announcements
    • 11.2.1. Aug 31, 2015: bioMerieux - First-Half 2015 Results
    • 11.2.2. Aug 25, 2015: EDAP Provides Formal Response to FDA Addressing All Concerns Raised in July 2015 Ablatherm HIFU Letter
    • 11.2.3. Aug 25, 2015: High Throughput Single-Cell mRNA Sequencing Preparation Comes to the Fluidigm C1 System
    • 11.2.4. Aug 25, 2015: SPR Therapeutics Awarded $1.6M NIH Grant to Study Pain Management Following Knee Replacement Surgery Using the Sprint PNS System
    • 11.2.5. Aug 25, 2015: Xtant Medical Announces FDA Approval of OsteoSelect PLUS
    • 11.2.6. Aug 25, 2015: Multi-center ALS Study Using the NeuRx Diaphragm Pacing System Shows Safety and Survival Post-Implant of 20.9 Months
    • 11.2.7. Aug 07, 2015: Interim financial report for Q2 2015 - the BioPorto Group
    • 11.2.8. Jul 29, 2015: QIAGEN reports results for second quarter and first half of 2015
    • 11.2.9. Jul 23, 2015: Roche delivers strong performance in the first half of 2015
    • 11.2.10. May 05, 2015: QIAGEN Reports Results for First Quarter 2015
    • 11.2.11. Apr 23, 2015: bioMerieux - First-Quarter 2015 Business Review
    • 11.2.12. Apr 23, 2015: bioMerieux - First-Quarter 2015 Business Review
    • 11.2.13. Apr 22, 2015: Roche reports strong sales growth in the first quarter of 2015
    • 11.2.14. Mar 24, 2015: Biotest increases sales by 16.2%
    • 11.2.15. Mar 19, 2015: AHN Offers Innovative Minimally-Invasive Surgical Procedure for Patients with Common, Yet Difficult to Diagnose, Form of Recurring Back Pain
    • 11.2.16. Mar 18, 2015: Blue Belt Technologies Announces First Navio Case Performed in Australia and First Navio-assisted GRU Unicompartmental Knee Replacement
    • 11.2.17. Mar 17, 2015: LG Health receives first upgrade to its CyberKnife M6 System
    • 11.2.18. Mar 17, 2015: Mediware to Unveil CareTend Software at NHIA Conference
    • 11.2.19. Mar 11, 2015: bioMerieux - 2014 Financial Results
    • 11.2.20. Mar 03, 2015: Oxford Immunotec Reports Fourth Quarter and Full Year 2014 Financial Results
    • 11.2.21. Feb 13, 2015: Biotest increases revenues significantly by 16.2%
    • 11.2.22. Feb 12, 2015: FDA Classifies Previous Covidien Field Action for Its Trellis-6 Peripheral Infusion Systems As a Class 1 Recall
    • 11.2.23. Dec 31, 2014: bioMerieux - Business Review for the Three Months and Full Year Ended December 31, 2014
    • 11.2.24. Nov 12, 2014: Biotest Increases Sales By 11,5% Compared To Previous Year
  • 11.3. Legal And Regulatory
    • 11.3.1. Jun 30, 2015: ImmunID Receives Accreditation From College of American Pathologists
  • 11.4. Other Significant Developments
    • 11.4.1. Sep 11, 2015: For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices
    • 11.4.2. Jul 17, 2015: bioMerieux - First-Half 2015 Business Review
    • 11.4.3. May 07, 2015: Biotest increases revenues by 16,6%
    • 11.4.4. Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche
    • 11.4.5. Mar 18, 2015: THERADIAG reinforces its RD and production capacities in new state-of-the-art facility
    • 11.4.6. Dec 15, 2014: SQI Diagnostics Wins Additional Business from UK-based Customer
    • 11.4.7. Oct 23, 2014: £230 million for technologies to revolutionise research into disease
    • 11.4.8. Sep 30, 2014: Biomerieux - Business Review for the Nine Months Ended September 30, 2014
  • 11.5. Product News
    • 11.5.1. Apr 27, 2015: NAT comments on the release of the first HIV self-test
    • 11.5.2. Oct 22, 2014: m2p-labs Supports Research Project in Synthetic Biology
    • 11.5.3. Oct 21, 2014: GENETWORx Launches a New Personal Health Panel for Advanced Diagnosis of Genital and Gastrointestinal Pathogens
  • 11.6. Strategy And Business Planning
    • 11.6.1. Sep 01, 2015: Mobidiag and Unilabs Enter into Agreement over Use of Amplidiag Product Line for Molecular Gastrointestinal Diagnostics
    • 11.6.2. Aug 12, 2015: CINDE Announces Pharmaceutical Invested $5.5 Million for New Headquarters
    • 11.6.3. Jul 01, 2015: Roche lays foundation stone of new IT innovation centre in Kaiseraugst
    • 11.6.4. May 04, 2015: QIAGEN Partners With World's Largest Sequencing Provider
    • 11.6.5. Apr 20, 2015: Curetis Expands Commercial Organization
    • 11.6.6. Jan 19, 2015: Roche opens new Learning Center in Kaiseraugst
    • 11.6.7. Oct 28, 2014: NovaBiotics Establishes a US Presence
    • 11.6.8. Oct 10, 2014: bioMerieux Inaugurates A New Multidisciplinary R&D Center For Infectious Disease Diagnostics

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Company Share Analysis
    • 12.1.5. Distribution Share Analysis
  • 12.2. GlobalData Consulting
  • 12.3. Contact Us
  • 12.4. Disclaimer

List of Tables

  • Table 1: Infectious Diagnostics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Infectious Diagnostics Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Infectious Diagnostics Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Infectious Diagnostics Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Infectious Diagnostics Market, EU5, Company Share by Revenue ($m), USD Constant, 2014
  • Table 6: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 7: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 9: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 10: Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 11: Infectious Diagnostics Market, France, Company Share by Revenue ($m), USD Constant, 2014
  • Table 12: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 13: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 14: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 15: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Infectious Diagnostics Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 17: Infectious Diagnostics Market, Germany, Company Share by Revenue ($m), USD Constant, 2014
  • Table 18: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 19: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 20: Infectious Diagnostics Rapid Tests & POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 21: Infectious Diagnostics Rapid Tests & POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 22: Infectious Diagnostics Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 23: Infectious Diagnostics Market, Italy, Company Share by Revenue ($m), USD Constant, 2014
  • Table 24: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 25: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 26: Infectious Diagnostics Rapid Tests & POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 27: Infectious Diagnostics Rapid Tests & POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 28: Infectious Diagnostics Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 29: Infectious Diagnostics Market, Spain, Company Share by Revenue ($m), USD Constant, 2014
  • Table 30: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 31: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 32: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 33: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 34: Infectious Diagnostics Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 35: Infectious Diagnostics Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014
  • Table 36: Infectious Diagnostics Market Pipeline Products

List of Figures

  • Figure 1: Infectious Diagnostics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Infectious Diagnostics Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Infectious Diagnostics Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Infectious Diagnostics Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Infectious Diagnostics Market, EU5, Company Share (%) 2014
  • Figure 6: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 7: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 9: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 10: Infectious Diagnostics Market, France, Company Share (%) 2014
  • Figure 11: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 13: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 14: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 15: Infectious Diagnostics Market, Germany, Company Share (%) 2014
  • Figure 16: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 17: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 18: Infectious Diagnostics Rapid Tests & POC Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 19: Infectious Diagnostics Rapid Tests & POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 20: Infectious Diagnostics Market, Italy, Company Share (%) 2014
  • Figure 21: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 22: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 23: Infectious Diagnostics Rapid Tests & POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 24: Infectious Diagnostics Rapid Tests & POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 25: Infectious Diagnostics Market, Spain, Company Share (%) 2014
  • Figure 26: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 27: Infectious Diagnostics Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 28: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 29: Infectious Diagnostics Rapid Tests & POC Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 30: Infectious Diagnostics Market, United Kingdom, Company Share (%) 2014
Back to Top